We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Dedicated Bioprocess Analyzer Monitors Fermenter Growth of Cell Cultures

By LabMedica International staff writers
Posted on 22 Sep 2011
A dedicated analyzer designed to provide a safe and reliable means for determining the chemical and biochemical parameters generated during fermenter growth of bacterial or mammalian cell cultures is now available for biotech and life science researchers.

The new Cedex Bio Bioprocess Analyzer is being marketed by Roche (Basel, Switzerland), one of the world’s largest producers of scientific instruments.

Cedex is a compact desktop system designed to fulfill the essential needs for metabolite screening and substrate analysis of bioprocesses. More...
It is able to perform photometric and electrolyte testing of up to 14 parameters simultaneously (out of 28 programmable tests) per sample. The instrument is easy to operate, enabling continuous loading and unloading of diverse cup types as well as having on-board dilution capability for highly concentrated samples.

The system is based on Roche’s well-known “cobas” technology and has built-in programs for the determination of glucose, lactate, LDH, ammonia, Na+, K+, glutamine, and glutamate. New parameters can be implemented by “plug and play,“ and a development channel for individual assay customization is planned.

“Bioprocess analytics are performed throughout the process from cell line development to large scale manufacturing of commercialized therapeutics. The majority of testing takes place during the upscale from plate-size to preclinical or early clinical studies supply – this is where the Cedex Bio Bioprocess Analyzer fits in perfectly. It is an accurate and reliable tool, providing bioprocess metabolite profiling, which is critical for the optimal production of biotherapeutics,” said Thomas Baier, head of global marketing for Roche Applied Science.

Related Links:
Roche




Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The blood-based assay captures circulating chromatin, cell-free DNA fragments that are largely inaccessible through standard laboratory methods (image credit: Shuttertstock)

Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

Sarcomas remain difficult to monitor during immunotherapy, as low tumor mutation burden can limit traditional circulating tumor DNA approaches and repeat tissue biopsies are often impractical in advanced disease.... Read more

Immunology

view channel
Image: New research shows that autoimmunity drives debilitating long COVID symptoms in a subset of patients (Image credit: Shutterstock)

Study Points to Autoimmune Pathway Behind Long COVID Symptoms

Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.